Nuclear Medicine - A Global Update of Market Trends & Opportunities

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND OUTLOOK
Market Snapshots
Outlook
Trends and Issues
Market Shifts to Hybrid Imaging
PET Makes Inroads into Conventional Gamma Camera Market
Diagnostic Imaging Witnesses Dramatic Growth
Aging Population and Healthy Reimbursement Drive Procedure Volumes
Technology Innovations Promise Bright Prospects
Competition
Leading Players in the Worldwide Nuclear Medicine Market: A- Completive Analysis
3.PRODUCT FACTS
Nuclear Medicine
Gamma Cameras
PET Scanners
Research and Development
Philips and University Medical Center Hamburg-Eppendorf Develop MRI/PET Imaging Tool
Indian Scientists Develop Low-Cost Nuclear Medicine Kit
4.CORPORATE DEVELOPMENTS
Orbotech to Acquire Danish Diagnostic Development
Covidien Imaging Solution Signs Agreement with BioSynthema
Digirad Takes Over Ultrascan
Triad Isotopes Acquires Three Major Nuclear Pharmacies
International Isotopes Acquires Stake in RadQual
Teleradiology and National Healthcare Group Enter into Joint Venture
Philips and Bioscan Sign Marketing Agreement
Mubadala Signs Contract with Siemens
HealthCare Global and GE Healthcare Establish Advanced Molecular Imaging- Center
International Atomic Energy Agency Establishes Gamma Camera Laboratory
Philips Launches MOSAIC HP Imaging System
Digirad Launches nSPEEDsm
Philips Introduces PET/CT Pulmonary Toolkit
Siemens to Introduce New High Definition PET-CT
Philips Extends Availability of PET/CT Viewer to iSite PACS Settings
Philips Announces Commercial Availability of JETStream Workspace 3.0
Philips Launches NanoSPECT/CT
Philips Announces Improvements to GEMINI TF PET/CT System
5.MAJOR PLAYERS
Digirad Corporation (USA)
GE Healthcare Plc (The United Kingdom)
Mallinckrodt, Inc. (USA)
Molypharma S.A. (Spain)
Orbotech Medical Solutions Ltd. (Israel)
Positron Corporation (USA)
IS2 Medical Systems (Canada)
Siemens Medical Solutions USA, Inc. (USA)
Toshiba Medical Systems Corporation (Japan)
Toshiba America Medical Systems, Inc. (USA)
6.GLOBAL MARKET ANALYTICS
7.THE UNITED STATES
Nuclear Medicine – Key Features
Market Trends
Nuclear Medicine Procedures on the Rise
Upsurge in Use of PET Scanners
Gamma Cameras: Gaining a Niche in Cardiac Imaging
Nuclear Cardiology: Primary Growth Propellant
Shift Towards Hospital-based PET Procedures from Outpatient Facilities
Growth in PET Procedure Volumes: Key Market Driver
Reimbursement Scenario
Competition
Gamma Cameras
PET Scanners
8.CANADA
Canada Faces Serious Issue over Paucity of PET Scanners
9.JAPAN
Market Scenario
10.EUROPE
a.France
b.Germany
c.The United Kingdom
d.Italy
e.Spain
f.Rest of Europe
11.ASIA-PACIFIC
Market Overview
Major Markets
China
Korea
12.REST OF WORLD
Major Markets
The Middle East
Latin America
Exhibits
Table 1: Percentage Breakdown of Leading Players in the Global Gamma Camera Market –
Table 2: Percentage Breakdown of Leading Players in the Global PET Scanner Market –
Table 3: Estimated Prices of Nuclear Medicine Systems
Table 4: Global Nuclear Medicine Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 5: Percentage Breakdown (Value Sales) of Global Nuclear Medicine Market by Region for the Years 2008 & 2009
Table 6: Global Gamma Cameras Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 7: Percentage Breakdown (Value Sales) of Global Gamma Cameras Market by Region for the Years 2008 & 2009
Table 8: Global PET Scanners Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown (Value Sales) of Global PET Scanners Market by Region for the Years 2008 & 2009
Table 10: Nuclear Medicine Procedures Performed in the US by Procedure Type – 2007-2010 (in millions)
Table 11: Percentage Breakdown of Leading Players in the US Gamma Camera Market – 2007E
Table 12: Percentage Breakdown of Leading Players in the US Cardiology Gamma Camera Market –
Table 13: Percentage Breakdown of Leading Players in the US PET Scanner Market –
Table 14: Nuclear Medicine Market by Product Segment in the US: 2007-2015 (Sales in Units)
Table 15: Percentage Breakdown (Volume Sales) of Nuclear Medicine Market by Product Segment in the US for the Years 2008 & 2009
Table 16: Nuclear Medicine Market by Product Segment in the US: 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in the US for the Years 2008 & 2009
Table 18: Nuclear Medicine Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Canada for the Years 2008 & 2009
Table 20: Nuclear Medicine Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Japan for the Years 2008 & 2009
Table 22: Nuclear Medicine Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Region in Europe for the Years 2008 & 2009
Table 24: Nuclear Medicine Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Europe for the Years 2008 & 2009
Table 26: Nuclear Medicine Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in France for the Years 2008 & 2009
Table 28: Nuclear Medicine Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Germany for the Years 2008 & 2009
Table 30: Percentage Breakdown of Nuclear Medicine Market by Technology in the UK –
Table 31: Nuclear Medicine Market by Product Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 32: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in the UK for the Years 2008 & 2009
Table 33: Nuclear Medicine Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 34: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Italy for the Years 2008 & 2009
Table 35: Nuclear Medicine Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 36: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Spain for the Years 2008 & 2009
Table 37: Nuclear Medicine Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 38: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Rest of Europe for the Years 2008 & 2009
Table 39: Nuclear Medicine Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 40: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Asia-Pacific for the Years 2008 & 2009
Table 41: Nuclear Medicine Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 42: Percentage Breakdown (Value Sales) of Nuclear Medicine Market by Product Segment in Rest of World for the Years 2008 & 2009
Companies Profiled